Data / Form D filings / WindMIL Therapeutics, Inc.
WindMIL Therapeutics, Inc.: Form D filings
WindMIL Therapeutics, Inc., a biotechnology company in Philadelphia, PA, filed 3 Form D notices with the SEC between 2016 and 2021. The latest, on February 5, 2021, reports $2.3 million sold of a $5 million offering to 11 investors.
Find out what WindMIL Therapeutics, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3675 MARKET STREET, SUITE 200, Philadelphia, PA, 19104
- Phone
- (410) 558-1906
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1671352
The full lists. Form D filings in Pennsylvania: 987 rows, $49.35, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 5, 2021 | New notice | $5,000,000 | $2,334,814 | $2,665,186 | 11 | Jan 26, 2021 | sec.gov |
| Jun 15, 2018 | New notice | $32,525,358 | $32,525,358 | $0 | 11 | Jun 1, 2018 | sec.gov |
| Apr 7, 2016 | New notice | $10,000,000 | $10,000,000 | $0 | 4 | Mar 29, 2016 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Donald J. Hayden, Jr. | Executive Officer, Director | |
| Patrick J. Fabbio | Executive Officer | |
| Howard J. Soule | Director | |
| Daniel J. O'Donnell | Director | |
| Mark J. McDade | Director | |
| Anna J. French | Director | |
| Brian J. Dovey | Director |
Other biotechnology companies in Pennsylvania that filed recently
- Traws Pharma, Inc. offering · Nov 5, 2026
- BioLattice Ophthalmics, Inc, $1.8 million · Oct 28, 2026
- Myris Therapeutics, Inc. $500,000 · Oct 14, 2026
- Praeventix, Inc. $5.6 million · Sep 10, 2026
- Plowshare Therapies LLC $6.7 million · Aug 31, 2026
- Noveome Biotherapeutics, Inc. $6.8 million · Aug 27, 2026
- AlloTRx Bio Inc. $500,000 · Aug 24, 2026
- Aposture Surgical Corp $87,000 · Aug 13, 2026
- Merlin Biotech, Inc. $50,000 · Aug 11, 2026
Every Form D from the week of Feb 1, 2021 · All recent filings in Pennsylvania · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what WindMIL Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.